BeiGene Ltd (BGNE)
176.50
+1.78
(+1.02%)
USD |
NASDAQ |
Dec 20, 16:00
177.10
+0.60
(+0.34%)
After-Hours: 20:00
BeiGene Shareholders Equity (Quarterly): 3.436B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Theravance Biopharma Inc | 185.65M |
| Merck & Co Inc | 44.50B |
| Dr Reddy's Laboratories Ltd | 3.647B |
| Bristol-Myers Squibb Co | 17.14B |
| Zai Lab Ltd | 667.67M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.831B |
| Total Liabilities (Quarterly) | 2.395B |
| Debt to Equity Ratio | 0.306 |
| Current Ratio | 1.931 |
| Net Debt Paydown Yield | -0.35% |